Biotech

All Articles

Amgen documents first stage 3 gain for $400M dermatitis medicine

.Amgen has actually discussed (PDF) the very first stage 3 information on its own $400 million eczem...

Biogen, UCB report period 3 lupus gain after failing earlier trial

.Biogen as well as UCB's gamble on developing right into stage 3 on the back of a broken research tr...

Aptadir really hopes new RNA preventions can turn around tricky cancers cells

.Italian biotech Aptadir Therapies has actually introduced with the assurance that its own pipe of p...

Wave surfs DMD effectiveness to regulators' doors, delivering stockpile

.Surge Lifestyle Sciences has met its own objective in a Duchenne muscle dystrophy (DMD) study, inst...

Sanofi picks brand-new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is going back to the pharma layer, taking ...

Achilles drops cell therapy course, prepares for discharges after missing 'business practicality' targets

.Achilles Rehabs has destroyed its own approach. The British biotech is actually quiting working on ...

Aligos declares stage 2 MASH win, lowering liver body fat up to 46%

.Aligos Therapies is declaring a midstage succeed in metabolic-dysfunction affiliated steatohepatiti...

Basilea credit ratings $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's work establishing brand-new antifungals has obtained a substantial improvem...

Capricor markets Europe legal rights to late-stage DMD treatment for $35M

.Possessing actually gathered up the united state legal rights to Capricor Therapies' late-stage Duc...

FDA scraps adcomm for Applied's uncommon health condition drug

.After pushing the decision meeting for Applied Therapeutics' metabolic problem medicine govorestat,...